Endurant Capital Management LP / ABT
Endurant Capital Management LP’s Abbott Laboratories Position
Does Endurant Capital Management LP own Abbott Laboratories (ABT)? Not currently — the last reported position was 18.0K shares worth $2M in Q3 2023; the fund’s latest 13F (Q1 2024) no longer reports it.
Position Value
$2M
Q3 2023
Shares
18.0K
% of Portfolio
+1.57%
Quarters Held
2
position exited
Position History ABT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of ABT.